Another study has shown that VWF tumour mRNA levels correlated with its VWF serum protein levels in patients with HER2-negative breast cancer, suggesting that VWF might be produced by tumour cells with an outflow to the systemic circulation [44]. Here, VWF is linked to breast carcinoma.